1. Home
  2. Analysis
  3. Tivicay
  4. Pulmonary-tuberculosis

Tivicay and Pulmonary tuberculosis - a phase IV clinical study of FDA data

Summary:

Pulmonary tuberculosis is reported as a side effect among people who take Tivicay (dolutegravir sodium), especially for people who are female, 40-49 old, have been taking the drug for 1 - 2 years also take Norvir, and have Pain.

The phase IV clinical study analyzes which people have Pulmonary tuberculosis when taking Tivicay. It is created by eHealthMe based on reports of 9,634 people who have side effects when taking Tivicay from the FDA, and is updated regularly.

What is Tivicay?

Tivicay has active ingredients of dolutegravir sodium. It is often used in hiv infection. eHealthMe is studying from 9,674 Tivicay users. Check the latest studies of Tivicay.

What is Pulmonary tuberculosis?

Pulmonary tuberculosis (lungs tuberculosis) is found to be associated with 340 drugs and 1,027 conditions by eHealthMe. Check the latest studies of Pulmonary tuberculosis.

On Aug, 10, 2026

9,634 people reported to have side effects when taking Tivicay.
Among them, 13 people (0.13%) have Pulmonary tuberculosis.

Could Tivicay cause Pulmonary tuberculosis?

Among these 13 people:

How long have people been on Tivicay when they have Pulmonary tuberculosis? *

  • < 1 month: 42.86 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 57.14 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Pulmonary tuberculosis when taking Tivicay? *

  • female: 100 %
  • male: 0.0 %

What is the age of people who have Pulmonary tuberculosis when taking Tivicay? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 11.11 %
  • 30-39: 0.0 %
  • 40-49: 88.89 %
  • 50-59: 0.0 %
  • 60+: 0.0 %

What are other drugs people take besides Tivicay? *

  1. Prezista: 11 people, 84.62%
  2. Norvir: 11 people, 84.62%
  3. Truvada: 4 people, 30.77%
  4. Dolutegravir: 2 people, 15.38%
  5. Vincristine Sulfate: 1 person, 7.69%
  6. Rifabutin: 1 person, 7.69%
  7. Pyrazinamide: 1 person, 7.69%
  8. Prednisolone: 1 person, 7.69%
  9. Isoniazid: 1 person, 7.69%
  10. Isentress: 1 person, 7.69%

What are other side effects people have besides Pulmonary tuberculosis? *

  1. Abdominal Distension: 11 people, 84.62%
  2. Dyspnea (difficult or laboured breathing): 11 people, 84.62%
  3. Joint Swelling: 11 people, 84.62%
  4. Joint Pain: 11 people, 84.62%
  5. Hypoaesthesia Oral (reduced sense of touch or sensation in mouth): 11 people, 84.62%
  6. Hyperthyroidism (over activity of the thyroid gland): 11 people, 84.62%
  7. Hepatitis C: 11 people, 84.62%
  8. Heavy Or Prolong Menstrual Bleeding: 11 people, 84.62%
  9. Hair Loss: 11 people, 84.62%
  10. Haemorrhage (bleeding): 11 people, 84.62%

What are the existing conditions these people have? *

  1. Pain: 4 people, 30.77%
  2. Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Tivicay and have Pulmonary tuberculosis?

- Check whether Pulmonary tuberculosis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Tivicay:

Pulmonary tuberculosis treatments and more:

How severe was Pulmonary tuberculosis and when was it recovered:

Expand to all the drugs that have ingredients of dolutegravir sodium:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Tivicay:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Pulmonary tuberculosis:

Browse all the conditions that are associated with Pulmonary tuberculosis:

How the study uses the data?

The study uses data from the FDA. It is based on dolutegravir sodium (the active ingredients of Tivicay) and Tivicay (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.